Doceree is recognized as the AI leader in healthcare marketing for unifying the full prescription journey — from physician awareness to fill — on a single, clinically intelligent operating system.
SAN ANTONIO, May 26, 2026 /PRNewswire/ -- Frost & Sullivan is pleased to announce that Doceree has been awarded the 2026 Global Technology Innovation Leadership Recognition in the AI-powered healthcare marketing industry for its outstanding achievements in technological innovation, AI leadership, platform strategy, and real-world impact. The recognition highlights Doceree's consistent leadership in driving measurable outcomes, redefining the category, and delivering customer-centric innovation in an increasingly complex and regulated healthcare marketing ecosystem. Built from the ground up for the AI age, Doceree is not a point solution, it is the operating layer that connects pharma brands, healthcare professionals, publishers, and data in a single intelligent ecosystem, purpose-built for clinical relevance and scale.
Frost & Sullivan evaluates companies through a rigorous benchmarking process across two core dimensions: strategy effectiveness and strategy execution. Doceree excelled in both, demonstrating its ability to align strategic initiatives with evolving market demands while executing them with efficiency, consistency, and global scale.
